BMS-183423

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBMS-183423
Drug Alias NameBMS-183423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine modulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A